FindTrial
Sign In

A single blinded, randomised study to compare efficacy and acceptability of magnesium sulfate capsules (Colocap: Balance) with sodium picosulfate (Pharmatel Fresenius Kabi: Picoprep) for bowel cleansing prior to colonoscopy.

A single blinded, randomised study to compare efficacy and acceptability of magnesium sulfate capsules (Colocap: Balance) with sodium picosulfate (Pharmatel Fresenius Kabi: Picoprep) for bowel cleansing prior to colonoscopy.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12608000269336
Enrollment
400
Registered
2008-05-28
Start date
2008-06-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Magnesium sulfate, encapsulated (65 capsules), total 61.75g (Colocap Balance), single administration before the procedure

Sponsors

Colocap Pharmaceuticals
Lead SponsorCommercial sector/Industry

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Diagnosis
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Presenting for elective colonoscopy

Exclusion criteria

Renal insufficiency, current chronic inflammatory bowel disease

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026